Skip to main content
Erschienen in: Supportive Care in Cancer 4/2004

01.04.2004 | Original Article

Is a specific oncological scoring system better at predicting the prognosis of cancer patients admitted for an acute medical complication in an intensive care unit than general gravity scores?

verfasst von: T. Berghmans, M. Paesmans, J. P. Sculier

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2004

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the effectiveness of a specific oncologic scoring system—the ICU Cancer Mortality model (ICM)—in predicting hospital mortality in comparison to two general severity scores—the Acute Physiology and Chronic Health Evaluation (APACHE II) and the Simplified Acute Physiology Score (SAPS II).

Patients and methods

All 247 patients admitted for a medical acute complication over an 18-month period in an oncological medical intensive care unit were prospectively registered. Their data, including type of complication, vital status at discharge and cancer characteristics as well as other variables necessary to calculate the three scoring systems were retrospectively assessed.

Results

Observed in-hospital mortality was 34%. The predicted in-hospital mortality rate for APACHE II was 32%; SAPS II, 24%; and ICM, 28%. The goodness of fit was inadequate except for the ICM score. Comparison of the area under the ROC curves revealed a better fit for ICM (area 0.79). The maximum correct classification rate was 72% for APACHE II, 74% for SAPS II and 77% for ICM. APACHE II and SAPS II were better at predicting outcome for survivors to hospital discharge, although ICM was better for non-survivors. Two variables were independently predicting the risk of death during hospitalisation: ICM (OR=2.31) and SAPS II (OR=1.05).

Conclusions

Gravity scores were the single independent predictors for hospital mortality, and ICM was equivalent to APACHE II and SAPS II.
Literatur
1.
Zurück zum Zitat Anonymous (1994) Second European Consensus Conference in Intensive Care: Predictory outcome in ICU patients. Réanimation-Urgences 3:141–234. Anonymous (1994) Second European Consensus Conference in Intensive Care: Predictory outcome in ICU patients. Réanimation-Urgences 3:141–234.
2.
Zurück zum Zitat Abbott RR, Setter M, Chan S, and Choi K (1991) APACHE II: Prediction of outcome of 451 ICU oncology admissions in a community hospital. Ann Oncol 2:571–574PubMed Abbott RR, Setter M, Chan S, and Choi K (1991) APACHE II: Prediction of outcome of 451 ICU oncology admissions in a community hospital. Ann Oncol 2:571–574PubMed
3.
Zurück zum Zitat Azoulay E, Moreau D, Alberti C, Leleu G, Adrie C, Barboteu M, Cottu P, Levy V, Le Gall J, Schlemmer B (2000) Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med, 26:1817–1823 Azoulay E, Moreau D, Alberti C, Leleu G, Adrie C, Barboteu M, Cottu P, Levy V, Le Gall J, Schlemmer B (2000) Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med, 26:1817–1823
4.
Zurück zum Zitat Blot F , Guignet M , Nitenberg G, Leclercq B, Gachot B, Escudier B(1997) Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer 33:1031–1037PubMed Blot F , Guignet M , Nitenberg G, Leclercq B, Gachot B, Escudier B(1997) Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer 33:1031–1037PubMed
5.
Zurück zum Zitat Boussat S, El’rini T, Dubiez A, Depierre A, Barale F, Capellier G (2000) Predictive factors of death in primary lung cancer patients on admission to the intensive care unit. Intensive Care Med 26:1811–1816CrossRefPubMed Boussat S, El’rini T, Dubiez A, Depierre A, Barale F, Capellier G (2000) Predictive factors of death in primary lung cancer patients on admission to the intensive care unit. Intensive Care Med 26:1811–1816CrossRefPubMed
6.
Zurück zum Zitat Brown M, Crede W (1995) Predictive ability of acute phisiology and chronic health evaluation II scoring applied to human immunodeficiency virus-positive patients. Crit care Med 23:848–853PubMed Brown M, Crede W (1995) Predictive ability of acute phisiology and chronic health evaluation II scoring applied to human immunodeficiency virus-positive patients. Crit care Med 23:848–853PubMed
7.
Zurück zum Zitat Brunet F, Lanore JJ, Dhainaut JF, Dreyfus F, Vaxelaire JF, Nouira S, Giraud T, Armaganidis A, Monsallier JF (1990) Is intensive care justified for patients with haematological malignancies? Intensive Care Med 16:291–297PubMed Brunet F, Lanore JJ, Dhainaut JF, Dreyfus F, Vaxelaire JF, Nouira S, Giraud T, Armaganidis A, Monsallier JF (1990) Is intensive care justified for patients with haematological malignancies? Intensive Care Med 16:291–297PubMed
8.
Zurück zum Zitat Chu D (1993) Predicting survival in AIDS patients with respiratory failure. Application of the APACHE II scoring system. Crit Care Clin 9:89–105PubMed Chu D (1993) Predicting survival in AIDS patients with respiratory failure. Application of the APACHE II scoring system. Crit Care Clin 9:89–105PubMed
9.
Zurück zum Zitat Giangiuliani G, Gui D, Bonatti P, Tozzi P, Caracciolo F (1990) APACHE II in surgical lung carcinoma patients. Chest 98:627–630PubMed Giangiuliani G, Gui D, Bonatti P, Tozzi P, Caracciolo F (1990) APACHE II in surgical lung carcinoma patients. Chest 98:627–630PubMed
10.
Zurück zum Zitat Groeger J, Lemeshow S, Price K, Nierman D, White P, Klar J, Granovsky S, Horak D, Kish S (1998) Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 16:761–770PubMed Groeger J, Lemeshow S, Price K, Nierman D, White P, Klar J, Granovsky S, Horak D, Kish S (1998) Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 16:761–770PubMed
11.
Zurück zum Zitat Haines IE, Zalcberg J, Buchanan JD (1990) Not for resuscitation orders in cancer patients-principles of decision making. Med J Aust 153:225–229PubMed Haines IE, Zalcberg J, Buchanan JD (1990) Not for resuscitation orders in cancer patients-principles of decision making. Med J Aust 153:225–229PubMed
12.
Zurück zum Zitat Hanley JA, McNeil BJ (1982) The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Radiology 143:29–36PubMed Hanley JA, McNeil BJ (1982) The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Radiology 143:29–36PubMed
13.
Zurück zum Zitat Headley J, Theriault R , Smith T (1992) Independent validation of APACHE II severity of illness score for predicting mortality in patients with breast cancer admitted to the intensive care unit. Cancer 70:497–503PubMed Headley J, Theriault R , Smith T (1992) Independent validation of APACHE II severity of illness score for predicting mortality in patients with breast cancer admitted to the intensive care unit. Cancer 70:497–503PubMed
14.
Zurück zum Zitat Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York
15.
Zurück zum Zitat Knaus W , Draper E , Wagner D, Zimmerman J (1985) APACHE II: A severity of disease classification system. Crit care Med 13:818–829PubMed Knaus W , Draper E , Wagner D, Zimmerman J (1985) APACHE II: A severity of disease classification system. Crit care Med 13:818–829PubMed
16.
Zurück zum Zitat Le Gall J, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963PubMed Le Gall J, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963PubMed
17.
Zurück zum Zitat Lemeshow S, Hosmer DW (1982) A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115:92–106PubMed Lemeshow S, Hosmer DW (1982) A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115:92–106PubMed
18.
Zurück zum Zitat Lemeshow S, Teres D, Klar J, Avrunin J, Gehlbach S, Rapoport J (1993) Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. JAMA 270:2478–2486PubMed Lemeshow S, Teres D, Klar J, Avrunin J, Gehlbach S, Rapoport J (1993) Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. JAMA 270:2478–2486PubMed
19.
Zurück zum Zitat Pierpont G, Parenti C (1999) Physician risk assessment and APACHE scores in cardiac care units. Clin Cardiol 22:366–368PubMed Pierpont G, Parenti C (1999) Physician risk assessment and APACHE scores in cardiac care units. Clin Cardiol 22:366–368PubMed
20.
Zurück zum Zitat Pittet D, Thievent B, Wenzel R, Li N, Gurman G, Suter P (1993) Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 19:265–272PubMed Pittet D, Thievent B, Wenzel R, Li N, Gurman G, Suter P (1993) Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 19:265–272PubMed
21.
Zurück zum Zitat Sculier J, Paesmans M, Markiewicz E, Berghmans T (2000) Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit. Crit care Med 28:2786–2792PubMed Sculier J, Paesmans M, Markiewicz E, Berghmans T (2000) Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit. Crit care Med 28:2786–2792PubMed
22.
Zurück zum Zitat Smith R, Levine S, Lewis M (1989) Prognosis of patients with AIDS requiring intensive care. Chest 96:857–861PubMed Smith R, Levine S, Lewis M (1989) Prognosis of patients with AIDS requiring intensive care. Chest 96:857–861PubMed
23.
Zurück zum Zitat Staudinger T, Stoiser B, Müllner M, Locker GJ, Laczika K, Knapp S, Burgmann H, Wilfing A, Kofler J, Thalhammer F, Frass M (2000) Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 28:1322–1328PubMed Staudinger T, Stoiser B, Müllner M, Locker GJ, Laczika K, Knapp S, Burgmann H, Wilfing A, Kofler J, Thalhammer F, Frass M (2000) Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 28:1322–1328PubMed
Metadaten
Titel
Is a specific oncological scoring system better at predicting the prognosis of cancer patients admitted for an acute medical complication in an intensive care unit than general gravity scores?
verfasst von
T. Berghmans
M. Paesmans
J. P. Sculier
Publikationsdatum
01.04.2004
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2004
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-003-0580-3

Weitere Artikel der Ausgabe 4/2004

Supportive Care in Cancer 4/2004 Zur Ausgabe

Forthcoming Meetings

March 2004

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.